|
Getting your Trinity Audio player ready...
|
Artificial Intelligence (AI) is transforming various sectors, and healthcare is one of the most promising fields. AI stocks can be a good play as AI is moving fast and getting adopted across industries.

Here’s why these 7 AI stocks could be good ones to add to your portfolio:
Two AI Stocks to Buy in Healthcare Robotics
#1 Vicarious Surgical Inc (RBOT)
Vicarious Surgical combines robotics with VR to make minimally invasive surgery better. They reduce the physical size of surgery while increasing precision and safety.
Why It’s a Great Pick:
- New Technology: Their VR enabled robots give surgeons an immersive experience, more precision.
- Cost Savings: Minimally invasive means shorter recovery times and hospital stays, cost savings.
- Market: Demand for surgical robots is growing as hospitals and surgical centers look to improve outcomes and efficiency.
#2 Intuitive Surgical Inc (ISRG)
Intuitive Surgical is the original robotic assisted, minimally invasive surgery company. da Vinci is used globally.
Why It’s a Great Pick:
- Market Leader: With a large market share, Intuitive Surgical has a solid foundation for growth.
- Continuous Innovation: The company invests in R&D, improving their systems and expanding their reach.
- Financials: Strong revenue and profitability shows company’s market position and operational efficiency.
Two AI Stocks to Buy in Medical Devices
#1 Medtronic PLC (MDT)
Medtronic is a global medical technology, services and solutions company. They are adding AI to their medical devices to improve performance and patient outcomes.
Why It’s a Great Pick:
- Diversified: Medtronic’s broad product and service portfolio across multiple medical fields reduces dependence on any one segment.
- AI: Using AI to improve device functionality and patient monitoring systems puts them at the forefront of medical innovation.
- Global: Global operations provide a steady revenue stream and growth opportunities in emerging markets.
#2 Butterfly Network, Inc (BFLY)
Butterfly Network has created a portable, AI-enabled ultrasound that can be attached to a smartphone. This makes medical imaging more accessible.
Why It’s a Great Pick:
- Accessibility: Their portable ultrasound democratizes access to medical imaging, especially in remote and underserved areas.
- AI: AI improves image quality and provides diagnostic support, more accuracy and efficiency.
- Growth: As demand for affordable and accessible medical imaging grows, Butterfly Network will benefit.
Three AI Stocks to Buy Now in Drug Discovery
#1 Recursion Pharmaceuticals, Inc (RXRX)
Recursion Pharmaceuticals uses AI to accelerate drug discovery by combining experimental biology, chemistry and advanced machine learning.
Why It’s a Great Pick:
- New Approach: Their platform can process massive datasets to find potential drug candidates faster than traditional methods.
- Partnerships: Partnerships with big pharma enhance their capabilities and market reach.
- Scalable: Their AI-driven approach is scalable, and could lead to many drug discoveries and treatments.
#2 Certara (CERT)
Certara provides biosimulation software and technology to optimize drug development and regulatory science, using AI to improve predictive models.
Why It’s a Great Pick:
- Advanced Biosimulation: Their AI-driven software improves drug development efficiency and success rates.
- Industry Wide: Widely used by pharma and regulatory agencies, proves trust and effectiveness.
- Revenue Growth: Strong financials with recurring revenue from software licenses and services.
#3 Schrödinger Inc (SDGR)
Schrödinger uses AI and physics-based computational platforms to transform drug discovery and materials science.
Why It’s a Great Pick:
- Next Gen Tech: Their platform combines AI with physics-based simulations, a unique and powerful approach to drug discovery.
- Partnerships: Partnerships with top biopharma companies proves their tech and expands their market.
The information provided on this platform is for general informational purposes only and is not intended to be financial, investment, tax, or legal advice. All information and content are provided in good faith; however, we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability, or completeness of any information on the site. You should not rely on this information as a substitute for professional advice. Always seek the advice of a qualified financial advisor or other relevant professional with any questions you may have regarding your financial situation. Any actions you take upon the information found on this platform are strictly at your own risk. We will not be liable for any losses or damages in connection with the use of our platform.